Organization
YourChoice Therapeutics
1 clinical trial
Clinical trial
Double-blind, Placebo Controlled, First in Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of YCT-529Status: Recruiting, Estimated PCD: 2024-06-01